A recent report published by Infinium Global
Research on the conjunctivitis market provides an in-depth analysis of segments and
sub-segments in the global as well as regional conjunctivitis market. The study
also highlights the impact of drivers, restraints, and macro indicators on the
global and regional conjunctivitis market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecast and dollar
values of the global conjunctivitis market. According to the report, the global
conjunctivitis market is projected to grow at a CAGR of 2.3% over the forecast
period of 2020-2026.
Conjunctivitis is a common cause of eye
redness that can affect people of any age, demographic, or socioeconomic
status. It is a common eye condition that affects more than 2% of the global
population annually. Viral, allergic, and bacterial conjunctivitis are the
three most common types of conjunctivitis among the population. A wide variety
of drugs and treatments are used to cure and relieve the symptoms of
conjunctivitis. Bacterial conjunctivitis is treated with ophthalmic antibiotic
eye drops or ointments, while, antihistamines are prescribed to treat allergic
conjunctivitis. Viral conjunctivitis does not have any treatments, however,
over-the-counter topical antihistamines and decongestants are used to relieve
symptoms. The global conjunctivitis market is characterized by the presence of
several treatments.
In the backdrop of the novel coronavirus
(COVID-19) pandemic, the way the health and development communities are
operating is rapidly changing. Routine out-patient visits and elective
surgeries have been advised to be suspended by ophthalmic societies and by the
government. Further, travel restrictions, reprioritization of health resources,
and economic consequences are impacting the work of many organizations.
Healthcare professionals need to attend to the patients requiring emergency
ophthalmic interventions during this pandemic. All these factors together are
anticipated to hamper the market over the short term. However, it is stated
that the COVID-19 virus can cause ocular complications such as conjunctivitis,
which may not be seen in the early stages of the disease. Though every patient
in the present scenario could be a potential source of COVID-19, patients with
conjunctivitis are being treated with greater fear, due to the possibility of
having symptom of COVID-19 and the probable risk of transmission from tears of
patients. This, in turn, is expected to boost the market growth for a shorter
period.
The increasing prevalence of conjunctivitis
patients across the globe and rising awareness among the population about pink
eye disease are the key driving factors for the growth of the conjunctivitis
market. The entry of new drugs and the increasing need for effective medication
for viral conjunctivitis are the key considering factors for the growth of the
conjunctivitis market. However, unfavorable government regulations and expiring
drug patents have impeded the demand for branded drugs restraining the growth
of this market. Furthermore, there are no approved drugs for the treatment of
viral conjunctivitis, many companies are developing drugs that are expected to
aid in the treatment of viral conjunctivitis and their effect will turn into a
prominent opportunity to promote the growth of this market over the forecast
period.
The global conjunctivitis market has been
regionally segmented into the geographies of North America, Europe, Asia
Pacific, and RoW. From a regional perspective, the North American region is
expected to dominate the market, attributed to the growing number of
conjunctivitis cases and the increasing demand for effective drugs. It is
estimated that around 6 million new cases of viral conjunctivitis occur
annually in the United States. Furthermore, the global market for
conjunctivitis has largely benefitted from a wide range of affordable generic
medications availability. Further, Asia Pacific will witness rapid growth in
the forecast period owing to the rapidly growing population and growing
awareness about medicines for treating conjunctivitis.
The report on global conjunctivitis market
covers segments such as disease type. On the basis of disease type, the
sub-markets include bacterial conjunctivitis, viral conjunctivitis, and
allergic conjunctivitis.
The report provides profiles of the companies
in the market such as Akorn Inc., Alcon Vision LLC, Allergan, Inc., Bausch
& Lomb Incorporated, Sesen Bio, Inc., Griffin Discoveries BV, InSite
Vision, Inc., Nicox SA, NovaBay Pharmaceuticals, Inc., and Ocular Therapeutix,
Inc..
The report provides deep insights into the
demand forecasts, market trends, and micro and macro indicators. In addition,
this report provides insights into the factors that are driving and restraining
the growth in this market. Moreover, The IGR-Growth Matrix analysis given in
the report brings an insight into the investment areas that existing or new
market players can consider. The report provides insights into the market using
analytical tools such as Porter's five forces analysis and DRO analysis of
conjunctivitis market. Moreover, the study highlights current market trends and
provides forecast from 2020-2026. We also have highlighted future trends in the
market that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.
Please Choose One of them.